CTLA4 and neoplasm: Enterococcus faecium induces synergistic antitumor effects of CTLA4 inhibitors via peptidoglycan fragments, which activate CX3CR1+ monocytes, stimulate cytotoxic lymphocytes to produce granzyme B, and reduce the number of tumor-associated macrophages (23).